Clinical Study
The Effects of Glucose Fluctuation on the Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus
Table 1
Comparison of the indexes in the three groups.
| | Group A | Group B | Group C |
| Sex (M/F) | 24/16 | 24/32 | 48/44 | Age (years) | | | *# | BMI (Kg/m2) | |
*
| | CD (year) | — | 6.10 (4.54, 8.11) | 4.73 (2.77, 7.70) | Antihypertension drug user (%) | 4 (10%) | 31 (55.4%)** | 55 (59.8%)** | SBP (mmHg) | | | **# | DBP (mmHg) | 70 (65–75) | 72 (66–79) | 80 (80-81)*# | HbA1c (%) | |
**
| **# | HDL-c (mmol/L) | 0.88 (0.83–0.92) | 0.96 (0.92–1.27)* | 0.91 (0.85–1.13) | LDL-c (mmol/L) | 2.16 (2.05–2.20) | 2.51 (1.78–2.92) | 2.17 (2.07–3.23) | TG (mmol/L) | 1.63 (1.58–1.66) | 2.12 (1.21–4.11) | 1.70 (1.42–2.23) | TC (mmol/L) | 4.14 (3.93–4.25) | 4.74 (4.05–4.79) | 4.11 (3.57–4.46) | GSH (mmol/L) | | | | MBG (mmol/L) | |
*
|
**
| MAGE (mmol/L) | 2.2 (1.8, 2.8) | 2.6 (1.9, 3.5)** | 4.0 (3.3, 4.8)**## | NEGE (times) | 6.8 (6.0, 7.7) | 4.1 (3.5, 4.7)** | 4.0 (3.4, 4.8)** | SDBG (mmol/L) | |
**
| **# | LAGE (mmol/L) | 2.9 (2.6–4.5) | 6.6 (5.8–12.4)** | 7.8 (6.1–9.9)** | PPGE1 (mmol/L) | 2.7 (1.6–4.3) | 3.2 (1.7–9.8) | 4.6 (3.2–8.1)** | PPGE2 (mmol/L) | 2.3 (1.7–3.5) | 2.4 (2.2–8.6) | 3.3 (2.6–5.4)* | PPGE3 (mmol/L) | | | **## | IMT (mm) | |
*
| **# | CRP (mg/L) | 1.0 (0.9–1.1) | 1.1 (1.0–2.8)* | 3.8 (2.8–5.4)**## | HOMA-IR | 1.58 (1.52–1.69) | 2.3 (1.9–9.1)** | 4.3 (3.0–4.9)** | HBCI | 87 (82–103) | 45 (28–67)** | 80 (48–139)## | SYNTAX score | — | 0 | |
|
|
CD: course of disease. Compared with group A, *, **; compared with group B, #, ##.
|